ITCI - Intra-Cellular Therapies Inc
IEX Last Trade
73.23
0.970 1.325%
Share volume: 603,112
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$72.26
0.97
1.34%
Fundamental analysis
28%
Profitability
25%
Dept financing
4%
Liquidity
75%
Performance
25%
Performance
5 Days
-1.61%
1 Month
-6.17%
3 Months
11.62%
6 Months
3.02%
1 Year
32.35%
2 Year
50.04%
Key data
Stock price
$73.23
DAY RANGE
N/A - N/A
52 WEEK RANGE
$45.50 - $84.89
52 WEEK CHANGE
$0.31
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Sharon Mates
Region: US
Website: http://www.intracellulartherapies.com/
Employees: 514
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.intracellulartherapies.com/
Employees: 514
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Recent news